Shares of Bath & Body Works, Inc. (NYSE: BBWI) declined 4.51% on November 17, closing at $18.40, compared with the previous close of $19.27. The stock showed signs of recovery in after-hours trading, rising 2.01% to $18.77. Investors are looking ahead to the company’s third-quarter fiscal 2027 earnings announcement scheduled for November 19, as the specialty retailer prepares to report its latest financial performance.
Bath & Body Works operates in the personal care and home fragrance market, offering products through its retail stores and e-commerce platforms in the United States, Canada, and international markets.
Stock Performance and Market Data
BBWI recorded a trading range of $18.20 to $19.29 during the session, opening at $19.06 before closing at $18.40. Trading volume reached approximately 8.63 million shares, exceeding its average volume of 6.79 million shares.
The company had an intraday market capitalization of approximately $3.71 billion and a 52-week trading range of $14.28 to $24.94. Its five-year monthly beta stood at 1.33, indicating relatively higher share-price volatility compared with the broader market.
Bath & Body Works reported trailing earnings per share of $3.80 and a price-to-earnings ratio of 4.84. The displayed one-year analyst price target was $24.93.
Business Overview and Product Portfolio
Headquartered in Columbus, Ohio, Bath & Body Works specializes in personal care and home fragrance products. Its portfolio includes three-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, hand soaps, body lotions, body creams, and hand sanitizers.
The company sells products under the Bath & Body Works brand and other brand names through its retail stores and e-commerce platforms. Its distribution network covers the United States and Canada, alongside international locations operated by partners through franchise, licensing, and wholesale arrangements.
Founded in 1963, the company was formerly known as L Brands, Inc. before changing its name to Bath & Body Works, Inc. in August 2021. It reported approximately 9,071 full-time employees.
Q3 2027 Earnings and Upcoming Events
Bath & Body Works is scheduled to hold its third-quarter fiscal 2027 earnings call on November 19, 2026, at 8:30 a.m. Eastern Time. The upcoming announcement will provide investors with an updated view of the company’s financial performance, operating trends, and business outlook.
The earnings release will be particularly relevant as investors assess the company’s sales performance, consumer demand, and ability to maintain profitability in the specialty retail market. The supplied market information does not include quarterly earnings estimates or revenue expectations.
Dividend Information
Bath & Body Works has a forward annual dividend of $0.80 per share, representing a displayed yield of approximately 4.15% based on the share price in the supplied data.
The next ex-dividend date is November 20, 2026, followed by a scheduled dividend payment on December 4, 2026. The dividend provides an additional consideration for investors evaluating the stock alongside its valuation and operating performance.
Closing Insights
Bath & Body Works shares experienced selling pressure during the November 17 session, declining 4.51% before recovering partially in after-hours trading. The upcoming November 19 earnings announcement represents the next major event for investors seeking greater clarity on the company’s financial position and retail performance.
Attention will focus on quarterly results, consumer spending trends, and management’s outlook for the remainder of fiscal 2027. The company’s dividend schedule and relatively low displayed price-to-earnings ratio may also remain relevant to investor assessments, although future share performance will depend on its operating results and broader market conditions.